Peter Scheurich

Title: Innovations and Contributions of Inventor Peter Scheurich

Introduction

Peter Scheurich is a notable inventor based in Stuttgart, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of five patents to his name, Scheurich's work has the potential to impact medical treatments significantly.

Latest Patents

Among his latest patents, Scheurich has developed monovalent anti-huTNFR1 antibodies, which include encoding nucleic acids and methods of treatment. This invention provides an inhibitor of the huTNFR1 receptor, characterized by specific CDR sequences, and includes a pharmaceutical preparation and methods for producing the inhibitor. Another significant patent involves huTNFR1 selective antagonists, which are ligands that specifically bind to the human tumor necrosis factor type 1 receptor. This invention aims to reduce the immunogenic response in humans and includes a nucleic acid sequence encoding the ligand along with a pharmaceutical composition for treating disorders related to huTNFR1.

Career Highlights

Peter Scheurich has worked with prestigious institutions such as the University of Stuttgart and the Fraunhofer Society for the Advancement of Applied Research. His career reflects a strong commitment to advancing scientific knowledge and developing innovative solutions in biotechnology.

Collaborations

Throughout his career, Scheurich has collaborated with esteemed colleagues, including Klaus Pfizenmaier and Roland Kontermann. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Peter Scheurich's innovative work in the field of biotechnology, particularly in the development of therapeutic antibodies, showcases his significant contributions to medical science. His patents and collaborations highlight the importance of teamwork in advancing research and innovation.